+358 40 6709390
Labquality is announcing a new EQA scheme for Interleukin-6 (IL-6). IL-6 is one of the major cytokines associated with Covid-19 induced cytokine storm. With the Covid-19 pandemic, there has been an increasing request for IL-6 EQA, which Labquality is proud to fulfil with this new EQA scheme.
The IL-6 pilot round will include three samples that should be analysed as regular patient samples. The participants submit their results through the electronic platform LabScala and results are processed by the EQA Coordinator. Result evaluations including comments by the Scheme Expert will be published in the final report distributed to the participants.
Round 1, 2021 in September will be a pilot study free of charge for a limited number of participants. At least two rounds will be included in the program of 2022.
Samples: 3 lyophilized samples
Distribution: 1, 2021 September – pilot study free of charge
Registration: Please register by August 15th, 2021 using this link (method information needed)
Participation: Limited number of samples available, participants will be selected according to methods in use.